| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.082 | 0.08 |